Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys

Siyu Chen; Jennifer A Flegg; Lisa J White; Ricardo Aguas.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-21249432

Documentos relacionados

  1. Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.
  2. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
  3. Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies.
  4. A simulation-based method to inform serosurvey design for estimating the force of infection using existing blood samples.
  5. Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020-February 2022.
  6. COVID-19 underreporting and its impact on vaccination strategies.
  7. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
  8. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.
  9. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
  10. SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency.